Volker Heinemann

This is a preview profile on BiomedExperts - the first literature-based scientific social network. It brings the right researchers together and allows them to collaborate online. Collexis and Dell provide the BiomedExperts network of +1.5 Million pre-calculated profiles free of charge to researchers worldwide.

Research Profile (preview)

Chemicals & Drugs

Procedures

Disorders

Concepts & Ideas

Sign-in to see full Profile

Sign-in to see all Coauthors

Publications

TOP 3
Schulz Christoph; Boeck Stefan; Heinemann Volker; Stemmler Hans-Joachim
UGT1A1 genotyping: a predictor of irinotecan-associated side effects and drug efficacy?
Schulz Christoph; Heinemann Volker; Schalhorn Andreas; Moosmann Nikolas; Zwingers Thomas; Boeck Stefan; Giessen Clemens; Stemmler Hans-Joachim
UGT1A1 gene polymorphism: impact on toxicity and efficacy of irinotecan-based regimens in metastatic colorectal cancer.
Dempke Wolfram C M; Heinemann Volker
Resistance to EGF-R (erbB-1) and VEGF-R modulating agents.

Sign-in to see all Publications

Sign in free and see...

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the visualized research activity
of experts around the globe

Sign-in to see more

Geonetwork of Volker Heinemann (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

Sign-in to see more

All Publications

2009: Schulz Christoph; Boeck Stefan; Heinemann Volker; Stemmler Hans-Joachim
UGT1A1 genotyping: a predictor of irinotecan-associated side effects and drug efficacy?
Anti-cancer drugs 2009;20(10):867-79.
2009: Schulz Christoph; Heinemann Volker; Schalhorn Andreas; Moosmann Nikolas; Zwingers Thomas; Boeck Stefan; Giessen Clemens; Stemmler Hans-Joachim
UGT1A1 gene polymorphism: impact on toxicity and efficacy of irinotecan-based regimens in metastatic colorectal cancer.
World journal of gastroenterology : WJG 2009;15(40):5058-66.
2009: Dempke Wolfram C M; Heinemann Volker
Resistance to EGF-R (erbB-1) and VEGF-R modulating agents.
European journal of cancer (Oxford, England : 1990) 2009;45(7):1117-28.
2009: Heinemann Volker; Stintzing Sebastian; Kirchner Thomas; Boeck Stefan; Jung Andreas
Clinical relevance of EGFR- and KRAS-status in colorectal cancer patients treated with monoclonal antibodies directed against the EGFR.
Cancer treatment reviews 2009;35(3):262-71.
2009: Heinemann V
[Medical-oncological aspects in the treatment of pancreatic cancer]
Der Radiologe 2009;49(2):144-8.
2009: Boeck Stefan; Bruns Christiane J; Sargent Mirja; Schafer Claus; Seufferlein Thomas; Jauch Karl-Walter; Heinemann Volker
Current oncological treatment of patients with pancreatic cancer in germany: results from a national survey on behalf of the Arbeitsgemeinschaft Internistische Onkologie and the Chirurgische Arbeitsgemeinschaft Onkologie of the Germany Cancer Society.
Oncology 2009;77(1):40-8.
2008: Heinemann V; Boeck S
Perioperative management of pancreatic cancer.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2008;19 Suppl 7():vii273-8.
2008: Stemmler Hans-Joachim; Heinemann Volker
Central nervous system metastases in HER-2-overexpressing metastatic breast cancer: a treatment challenge.
The oncologist 2008;13(7):739-50.
2008: Stemmler H-J; Heinemann V
[Oncology 2008]
Deutsche medizinische Wochenschrift (1946) 2008;133(25-26):1395-9.
2008: Moosmann Nicolas; Heinemann Volker
Cetuximab plus XELIRI or XELOX for first-line therapy of metastatic colorectal cancer.
Clinical colorectal cancer 2008;7(2):110-7.
2008: Boeck Stefan; Heinemann Volker
The role of second-line chemotherapy after gemcitabine failure in patients with advanced pancreatic cancer.
Future oncology (London, England) 2008;4(1):41-50.
2008: Boeck S; Hoehler T; Seipelt G; Mahlberg R; Wein A; Hochhaus A; Boeck H-P; Schmid B; Kettner E; Stauch M; Lordick F; Ko Y; Geissler M; Schoppmeyer K; Kojouharoff G; Golf A; Neugebauer S; Heinemann V
Capecitabine plus oxaliplatin (CapOx) versus capecitabine plus gemcitabine (CapGem) versus gemcitabine plus oxaliplatin (mGemOx): final results of a multicenter randomized phase II trial in advanced pancreatic cancer.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2008;19(2):340-7.
2008: Bauerfeind I; Kahlert S; Löhrs B; Heinemann V; Schaffer P; Hoffmann R T; Loeff G; Löhe F
[Metastatic breast cancer--surgical possibilities]
MMW Fortschritte der Medizin 2008;150(1-2):37-9.
2008: Rack B; Heinemann V; Schindlbeck C; Walther J; Salat C; Sommer H
[Metastatic breast cancer--new methods of treatment]
MMW Fortschritte der Medizin 2008;150(1-2):34-6.
2008: Kolligs F T; Zech C J; Schönberg S O; Schirra J; Thasler W; Graeb C; Beuers U; Wilkowski R; Jacobs T; Böck S; Berster J; Heinemann V; Schäfer C
[Interdisciplinary diagnosis of and therapy for cholangiocarcinoma]
Zeitschrift für Gastroenterologie 2008;46(1):58-68.
2008: Schmidt Gerwin P; Baur-Melnyk Andrea; Haug Alexander; Heinemann Volker; Bauerfeind Ingo; Reiser Maximilian F; Schoenberg Stefan O
Comprehensive imaging of tumor recurrence in breast cancer patients using whole-body MRI at 1.5 and 3 T compared to FDG-PET-CT.
European journal of radiology 2008;65(1):47-58.
2008: Heinemann Volker; Boeck Stefan; Hinke Axel; Labianca Roberto; Louvet Christophe
Meta-analysis of randomized trials: evaluation of benefit from gemcitabine-based combination chemotherapy applied in advanced pancreatic cancer.
BMC cancer 2008;8():82.
2007: Moosmann Nicolas; Laessig Dorit; Michaely Henrik Jakob; Schulz Christoph; Heinemann Volker
Effective second-line treatment with cetuximab and bevacizumab in a patient with hepatic metastases of colorectal cancer and hyperbilirubinemia.
Onkologie 2007;30(10):509-12.
2007: Boeck Stefan; Hausmann Andreas; Reibke Roland; Schulz Christoph; Heinemann Volker
Severe lung and skin toxicity during treatment with gemcitabine and erlotinib for metastatic pancreatic cancer.
Anti-cancer drugs 2007;18(9):1109-11.
2007: Lorenzen S; Hentrich M; Haberl C; Heinemann V; Schuster T; Seroneit T; Roethling N; Peschel C; Lordick F
Split-dose docetaxel, cisplatin and leucovorin/fluorouracil as first-line therapy in advanced gastric cancer and adenocarcinoma of the gastroesophageal junction: results of a phase II trial.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2007;18(10):1673-9.
2007: Heinemann V; Labianca R; Hinke A; Louvet C
Increased survival using platinum analog combined with gemcitabine as compared to single-agent gemcitabine in advanced pancreatic cancer: pooled analysis of two randomized trials, the GERCOR/GISCAD intergroup study and a German multicenter study.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2007;18(10):1652-9.
2007: Heinemann Volker; Moosmann Nicolas
[Neoadjuvant and adjuvant therapies for solid tumours]
MMW Fortschritte der Medizin 2007;149(35-36):27-30.
2007: Boeck S; Wollenberg A; Heinemann V
Leukocytoclastic vasculitis during treatment with the oral EGFR tyrosine kinase inhibitor erlotinib.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2007;18(9):1582-3.
2007: Haug Alexander Robert; Schmidt Gerwin Paul; Klingenstein Annemarie; Heinemann Volker; Stieber Petra; Priebe Markus; la Fougère Christian; Becker Christoph; Hahn Klaus; Tiling Reinhold
F-18-fluoro-2-deoxyglucose positron emission tomography/computed tomography in the follow-up of breast cancer with elevated levels of tumor markers.
Journal of computer assisted tomography 2007;31(4):629-34.
2007: Laessig Dorit; Nagel Dorothea; Heinemann Volker; Untch Michael; Kahlert Steffen; Bauerfeind Ingo; Stieber Petra
Importance of CEA and CA 15-3 during disease progression in metastatic breast cancer patients.
Anticancer research 2007;27(4A):1963-8.
2007: Moosmann Nicolas; Boeck Stefan; Heinemann Volker
[Importance of neoadjuvant chemotherapy in gastrointestinal tumors. A new standard?]
Medizinische Klinik (Munich, Germany : 1983) 2007;102(7):551-62; quiz 563-4.
2007: Wollenberg A; Moosmann N; Kroth J; Heinemann V; Klein E
[Therapy of severe cetuximab-induced acneiform eruptions with oral retinoid, topical antibiotic and topical corticosteroid]
Der Hautarzt; Zeitschrift für Dermatologie, Venerologie, und verwandte Gebiete 2007;58(7):615-8.
2007: Boeck S; Moosmann N; Stemmler H-J; Heinemann V
[Molecular-based treatment concepts in advanced pancreatic cancer]
Deutsche medizinische Wochenschrift (1946) 2007;132(15):818-22.
2007: Boeck S; Weigang-Köhler K; Fuchs M; Kettner E; Quietzsch D; Trojan J; Stötzer O; Zeuzem S; Lordick F; Köhne C-H; Kröning H; Steinmetz T; Depenbrock H; Heinemann V
Second-line chemotherapy with pemetrexed after gemcitabine failure in patients with advanced pancreatic cancer: a multicenter phase II trial.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2007;18(4):745-51.
2007: Boeck Stefan; Schulz Christoph; Stieber Petra; Holdenrieder Stefan; Weckbach Sabine; Heinemann Volker
Assessing prognosis in metastatic pancreatic cancer by the serum tumor marker CA 19-9: pretreatment levels or kinetics during chemotherapy?
Onkologie 2007;30(1-2):39-42.
2007: Moosmann Nicolas; Heinemann Volker
Cetuximab in the treatment of metastatic colorectal cancer.
Expert opinion on biological therapy 2007;7(2):243-56.
2007: Boeck Stefan; Hinke Axel; Wilkowski Ralf; Heinemann Volker
Importance of performance status for treatment outcome in advanced pancreatic cancer.
World journal of gastroenterology : WJG 2007;13(2):224-7.
2007: Stemmler Hans-Joachim; Schmitt Manfred; Willems Amina; Bernhard Helga; Harbeck Nadia; Heinemann Volker
Ratio of trastuzumab levels in serum and cerebrospinal fluid is altered in HER2-positive breast cancer patients with brain metastases and impairment of blood-brain barrier.
Anti-cancer drugs 2007;18(1):23-8.
2007: Laessig D; Stemmler H J; Vehling-Kaiser U; Fasching P A; Melchert F; Kolbl H; Stauch M; Maubach P; Scharl A; Morack G; Meerpohl H; Weber B; Kalischefski B; Heinemann V
Gemcitabine and carboplatin in intensively pretreated patients with metastatic breast cancer.
Oncology 2007;73(5-6):407-14.
2007: Boeck Stefan; Wilkowski Ralf; Bruns Christiane J; Issels Rolf D; Schulz Christoph; Moosmann Nicolas; Laessig Dorit; Haas Michael; Golf Alexander; Heinemann Volker
Oral capecitabine in gemcitabine-pretreated patients with advanced pancreatic cancer.
Oncology 2007;73(3-4):221-7.
2007: Boeck Stefan; Ankerst Donna Pauler; Heinemann Volker
The role of adjuvant chemotherapy for patients with resected pancreatic cancer: systematic review of randomized controlled trials and meta-analysis.
Oncology 2007;72(5-6):314-21.
2006: Fahrig Rudolf; Quietzsch Detlef; Heinrich Jörg-Christian; Heinemann Volker; Boeck Stefan; Schmid Roland M; Praha Christian; Liebert Andreas; Sonntag Denise; Krupitza Georg; Hänel Mathias
RP101 improves the efficacy of chemotherapy in pancreas carcinoma cell lines and pancreatic cancer patients.
Anti-cancer drugs 2006;17(9):1045-56.
2006: Heinemann Volker; Quietzsch Detlef; Gieseler Frank; Gonnermann Michael; Schönekäs Herbert; Rost Andreas; Neuhaus Horst; Haag Caroline; Clemens Michael; Heinrich Bernard; Vehling-Kaiser Ursula; Fuchs Martin; Fleckenstein Doris; Gesierich Wolfgang; Uthgenannt Dirk; Einsele Hermann; Holstege Axel; Hinke Axel; Schalhorn Andreas; Wilkowski Ralf
Randomized phase III trial of gemcitabine plus cisplatin compared with gemcitabine alone in advanced pancreatic cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2006;24(24):3946-52.
2006: Stemmler H J; Schmitt M; Harbeck N; Willems A; Bernhard H; Lässig D; Schoenberg S; Heinemann V
Application of intrathecal trastuzumab (Herceptintrade mark) for treatment of meningeal carcinomatosis in HER2-overexpressing metastatic breast cancer.
Oncology reports 2006;15(5):1373-7.
2006: Heinemann V; Stemmler H J; Wohlrab A; Bosse D; Losem C; Kahlert S; Rauthe G
High efficacy of gemcitabine and cisplatin in patients with predominantly anthracycline- and taxane-pretreated metastatic breast cancer.
Cancer chemotherapy and pharmacology 2006;57(5):640-6.
2006: Stemmler H J; Kahlert S; Siekiera W; Untch M; Heinrich B; Heinemann V
Characteristics of patients with brain metastases receiving trastuzumab for HER2 overexpressing metastatic breast cancer.
Breast (Edinburgh, Scotland) 2006;15(2):219-25.
2006: Boeck Stefan; Stieber Petra; Holdenrieder Stefan; Wilkowski Ralf; Heinemann Volker
Prognostic and therapeutic significance of carbohydrate antigen 19-9 as tumor marker in patients with pancreatic cancer.
Oncology 2006;70(4):255-64.
2006: Wilkowski Ralf; Thoma Martin; Bruns Christiane; Wagner Andreas; Heinemann Volker
Chemoradiotherapy with gemcitabine and continuous 5-FU in patients with primary inoperable pancreatic cancer.
JOP : Journal of the pancreas 2006;7(4):349-60.
2006: Wilkowski Ralf; Thoma Martin; Bruns Christiane; Dühmke Eckhard; Heinemann Volker
Combined chemoradiotherapy for isolated local recurrence after primary resection of pancreatic cancer.
JOP : Journal of the pancreas 2006;7(1):34-40.
2005: Stemmler H J; Kahlert S; Brudler O; Beha M; Müller S; Stauch B; Heinemann V
High efficacy of gemcitabine and cisplatin plus trastuzumab in patients with HER2-overexpressing metastatic breast cancer: a phase II study.
Clinical oncology (Royal College of Radiologists (Great Britain)) 2005;17(8):630-5.
2005: Stemmler Hans-Joachim; Kahlert Steffen; Siekiera Wolfgang; Untch Michael; Heinrich Bernhard; Heinemann Volker
Prolonged survival of patients receiving trastuzumab beyond disease progression for HER2 overexpressing metastatic breast cancer (MBC).
Onkologie 2005;28(11):582-6.
2005: Stemmler H J; Menzel H; Salat C; Lindhofer H; Kahlert S; Heinemann V; Kolb H J
Lasting remission following multimodal treatment in a patient with metastatic breast cancer.
Anti-cancer drugs 2005;16(10):1135-7.
2005: Hiddemann W; Heinemann V
[Current progress in therapy of malignant diseases]
Deutsche medizinische Wochenschrift (1946) 2005;130(31-32):1837-40.
2005: Stemmler H J; Salat C; Lindhofer H; Menzel H; Untch M; Kahlert S; Konecny G; Sauer H; Ledderose G; Heinemann V; Kolb H J
Combined treatment of metastatic breast cancer (MBC) by high-dose chemotherapy (HDCT) and bispecific antibodies: a pilot study.
Anticancer research 2005;25(4):3047-54.
2005: Stieber P; Heinemann V; Schalhorn A
[Tumor markers--how they should be applied]
MMW Fortschritte der Medizin 2005;147(20):35, 37-9.
2005: Wilkowski Ralf; Thoma Martin; Weingandt Helmut; Dühmke Eckhart; Heinemann Volker
Chemoradiation for ductal pancreatic carcinoma: principles of combining chemotherapy with radiation, definition of target volume and radiation dose.
JOP : Journal of the pancreas 2005;6(3):216-30.
2005: Stemmler Hans-Joachim; Stieber Petra; Lässig Dorit; Heinemann Volker
Re-evaluation of HER2 status in metastatic breast cancer and tumor-marker guided therapy with vinorelbine and trastuzumab.
Onkologie 2005;28(2):95-7.
2005: Stemmler J; Mair W; Stauch M; Papke J; Deutsch G; Abenhardt W; Dorn B; Kentenich C; Malekmohammadi M; Jackisch C; Leinung S; Brudler O; Vehling-Kaiser U; Stamp J; Heinemann V
High efficacy and low toxicity of weekly docetaxel given as first-line treatment for metastatic breast cancer.
Oncology 2005;68(1):71-8.
2004: Wilkowski Ralf; Thoma Martin; Schauer Rolf; Wagner Andreas; Heinemann Volker
Effect of chemoradiotherapy with gemcitabine and cisplatin on locoregional control in patients with primary inoperable pancreatic cancer.
World journal of surgery 2004;28(10):1011-8.
2004: Jehn U; Bartl R; Dietzfelbinger H; Haferlach T; Heinemann V
An update: 12-year follow-up of patients with hairy cell leukemia following treatment with 2-chlorodeoxyadenosine.
Leukemia : official journal of the Leukemia Society of America, Leukemia Research Fund, U.K 2004;18(9):1476-81.
2004: Wilkowski Ralf; Thoma Martin; Dühmke Eckhart; Rau Horst Günter; Heinemann Volker
Concurrent chemoradiotherapy with gemcitabine and cisplatin after incomplete (R1) resection of locally advanced pancreatic carcinoma.
International journal of radiation oncology, biology, physics 2004;58(3):768-72.
2003: Stemmler J; Stieber P; Szymala A M; Schalhorn A; Schermuly M M; Wilkowski R; Helmberger T; Lamerz R; Stoffregen C; Niebler K; Garbrecht M; Heinemann V
Are serial CA 19-9 kinetics helpful in predicting survival in patients with advanced or metastatic pancreatic cancer treated with gemcitabine and cisplatin?
Onkologie 2003;26(5):462-7.
2003: Wilkowski Ralf; Thoma Martin; Heinemann Volker; Rau Horst-Günter; Wagner Andreas; Stoffregen Clemens; Dühmke Eckhart
[Radiochemotherapy with gemcitabine and cisplatin in pancreatic cancer -- feasible and effective]
Strahlentherapie und Onkologie : Organ der Deutschen Röntgengesellschaft ... [et al] 2003;179(2):78-86.
2002: Heinemann Volker
Gemcitabine in the treatment of advanced pancreatic cancer: a comparative analysis of randomized trials.
Seminars in oncology 2002;29(6 Suppl 20):9-16.
2002: Stemmler J; Wittmann G W; Hacker U; Heinemann V
Leukapheresis in chronic myelomonocytic leukemia with leukostasis syndrome: elevated serum lactate levels as an early sign of microcirculation failure.
Leukemia & lymphoma 2002;43(7):1427-30.
2002: Stemmler H J; Kenngotte S; Diepolder H; Heinemann V
Gastrointestinal toxicity associated with weekly docetaxel treatment.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2002;13(6):978-81.
2002: Heinemann Volker
Present and future treatment of pancreatic cancer.
Seminars in oncology 2002;29(3 Suppl 9):23-31.
2002: Stemmler J; Heinemann V; Schalhorn A
Capecitabine as second-line treatment for metastatic cholangiocarcinoma: a report of two cases.
Onkologie 2002;25(2):182-4.
2002: Rau H G; Wichmann M W; Wilkowski R; Heinemann V; Sackmann M; Helmberger T; Dühmke E; Schildberg F W
[Surgical therapy of locally advanced and primary inoperable pancreatic carcinoma after neoadjuvant preoperative radiochemotherapy]
Der Chirurg; Zeitschrift für alle Gebiete der operativen Medizen 2002;73(2):132-7.
2002: Stemmler J; Weise A; Hacker U; Heinemann V; Schalhorn A
Weekly irinotecan in a patient with metastatic colorectal cancer on hemodialysis due to chronic renal failure.
Onkologie 2002;25(1):60-3.
2001: Stemmler H J; Gutschow K; Sommer H; Malekmohammadi M; Kentenich C H; Forstpointner R; Geuenich S; Bischoff J; Hiddemann W; Heinemann V
Weekly docetaxel (Taxotere) in patients with metastatic breast cancer.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2001;12(10):1393-8.
2000: Heinemann V; Wilke H; Mergenthaler H G; Clemens M; König H; Illiger H J; Arning M; Schalhorn A; Possinger K; Fink U
Gemcitabine and cisplatin in the treatment of advanced or metastatic pancreatic cancer.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2000;11(11):1399-403.
2000: Wilkowski R; Heinemann V; Rau H
[Locally advanced pancreatic carcinoma. Radiochemotherapy prolongs survival]
MMW Fortschritte der Medizin 2000;142(42):31-2.
1999: Heinemann V; Schermuly M M; Stieber P; Schulz L; Jüngst D; Wilkowski R; Schalhorn A
CA19-9: a pedictor of response in pancreatic cancer treated with gemcitabine and cisplatin.
Anticancer research 1999;19(4A):2433-5.
1999: Schwartz S; Behre G; Heinemann V; Wandt H; Schilling E; Arning M; Trittin A; Kern W V; Boenisch O; Bosse D; Lenz K; Ludwig W D; Hiddemann W; Siegert W; Beyer J
Aerosolized amphotericin B inhalations as prophylaxis of invasive aspergillus infections during prolonged neutropenia: results of a prospective randomized multicenter trial.
Blood 1999;93(11):3654-61.
1999: Jehn U; Bartl R; Dietzfelbinger H; Vehling-Kaiser U; Wolf-Hornung B; Hill W; Heinemann V
Long-term outcome of hairy cell leukemia treated with 2-chlorodeoxyadenosine.
Annals of hematology 1999;78(3):139-44.
1998: Jehn U; Heinemann V
Successful treatment of accelerated and blastic phase of chronic myeloid leukemia with high-dose interferon-alpha combined with hydroxyurea.
Cancer detection and prevention 1998;22(3):258-64.
1998: Heinemann V; Schulz L; Issels R D; Wilmanns W
Regulation of deoxycytidine kinase by deoxycytidine and deoxycytidine 5' triphosphate in whole leukemia and tumor cells.
Advances in experimental medicine and biology 1998;431():249-53.
1997: Heinemann V; Bosse D; Jehn U; Debus A; Wachholz K; Forst H; Wilmanns W
Enhanced pulmonary accumulation of liposomal amphotericin B (AmBisome) in acute liver transplant failure.
The Journal of antimicrobial chemotherapy 1997;40(2):295-7.
1997: Heinemann V; Bosse D; Jehn U; Kähny B; Wachholz K; Debus A; Scholz P; Kolb H J; Wilmanns W
Pharmacokinetics of liposomal amphotericin B (Ambisome) in critically ill patients.
Antimicrobial agents and chemotherapy 1997;41(6):1275-80.
1997: Heinemann V; Kähny B; Jehn U; Mühlbayer D; Debus A; Wachholz K; Bosse D; Kolb H J; Wilmanns W
Serum pharmacology of amphotericin B applied in lipid emulsions.
Antimicrobial agents and chemotherapy 1997;41(4):728-32.
1997: Salat C; Holler E; Wolf C; Kolb H J; Reinhardt B; Pihusch R; Krämling H J; Heinemann V; Haller M; Hiller E
Laboratory markers of veno-occlusive disease in the course of bone marrow and subsequent liver transplantation.
Bone marrow transplantation 1997;19(5):487-90.
1995: Behre G F; Schwartz S; Lenz K; Ludwig W D; Wandt H; Schilling E; Heinemann V; Link H; Trittin A; Boenisch O
Aerosol amphotericin B inhalations for prevention of invasive pulmonary aspergillosis in neutropenic cancer patients.
Annals of hematology 1995;71(6):287-91.
1995: Jehn U; Pötscher C; Heinemann V
Successful treatment of accelerated and blastic phase of chronic myeloid leukemia with high-dose interferon alpha and hydroxyurea: a novel approach.
Leukemia & lymphoma 1995;19(1-2):153-7.
1995: Heinemann V; Schulz L; Issels R D; Plunkett W
Gemcitabine: a modulator of intracellular nucleotide and deoxynucleotide metabolism.
Seminars in oncology 1995;22(4 Suppl 11):11-8.
1994: Heinemann V; Kähny B; Debus A; Wachholz K; Jehn U
Pharmacokinetics of liposomal amphotericin B (AmBisome) versus other lipid-based formulations.
Bone marrow transplantation 1994;14 Suppl 5():S8-9.
1993: Jehn U; Heinemann V
Phase II-study for treatment of refractory acute leukemia with intermediate-dose cytosine arabinoside and amsacrine.
Anticancer research 1993;13(2):379-81.
1993: Jehn U; Heinemann V
Phase-II study of treatment of refractory acute leukemia with intermediate-dose cytosine arabinoside and amsacrine.
Annals of hematology 1993;66(3):131-4.
1992: Lorenz T; Heinemann V; Jehn U
[Pancytopenia following non-A, non-B hepatitis]
Der Internist 1992;33(8):559-62.
1991: Heinemann V; Jehn U
Acute myeloid leukemia in the elderly: biological features and search for adequate treatment.
Annals of hematology 1991;63(4):179-88.
1991: Jehn U; Heinemann V
New drugs in the treatment of acute and chronic leukemia with some emphasis on m-AMSA.
Anticancer research 1991;11(2):705-11.
1990: Heinemann V; Jehn U
Rationales for a pharmacologically optimized treatment of acute nonlymphocytic leukemia with cytosine arabinoside.
Leukemia : official journal of the Leukemia Society of America, Leukemia Research Fund, U.K 1990;4(11):790-6.
1990: Jehn U; Heinemann V
Intermediate-dose Ara-C/m-AMSA for remission induction and high-dose Ara-C/m-AMSA for intensive consolidation in relapsed and refractory adult acute myelogeneous leukemia.
Haematology and blood transfusion 1990;33():333-8.
1989: Jehn U; Mittermüller J; Greither L; Clemm C; Heinemann V; Lorenz T; Gross H J
Repeated blast crisis (BC) of changing morphology, immunologic phenotype and cytogenetics in chronic myeloid leukemia (CML).
Anticancer research 1989;9(6):1721-3.
1989: Jehn U; Heinemann V; Wilmanns W
Intermediate-dose Ara-C/m-AMSA for remission induction and high-dose Ara-C/m-AMSA for intensive consolidation in relapsed and refractory adult acute myelogenous leukemia (AML).
Anticancer research 1989;9(1):119-24.

Sign-in to see more

Sign-in free and Explore the Exciting World of BiomedExperts:

NetworkView

Volker Heinemann

Research Profile (preview)

Chemicals & Drugs

Procedures

Disorders

Concepts & Ideas

Network (preview)

Publications

Sign in free and see...

Visualized networks:

GeoTargeted Searches:

Research Profiles:

Geonetwork of Volker Heinemann (preview)

All Publications